From Surf Wiki (app.surf) — the open knowledge base
Kalbe Farma
Indonesian pharmaceutical, healthcare and nutrition company
Indonesian pharmaceutical, healthcare and nutrition company
| Field | Value | |
|---|---|---|
| name | PT Kalbe Farma Tbk | |
| logo | Kalbe Farma.svg | |
| logo_caption | Current logo since 6 March 2007 | |
| type | Public | |
| traded_as | ||
| foundation | ||
| location | Jakarta, Indonesia | |
| area_served | Worldwide | |
| key_people | Vidjongtius (CEO) | |
| Bernadette Ruth Irawati Setiady (President) | ||
| num_employees | 16,235 (2021) | |
| products | Drugs, energy drinks, milk, baby food, healthy drinks, herbal supplements and nutrition products | |
| industry | ||
| revenue | Rp 26.261 trillion (2021) | |
| assets | Rp 25.667 trillion (2021) | |
| net_income | Rp 3.208 trillion (2021) | |
| equity | Rp 21.365 trillion (2021) | |
| subsid | {{Plainlist | |
| homepage |
Bernadette Ruth Irawati Setiady (President)
- Bintang Toedjoe
- Kalbe Nutritionals
- Kalbe Genexine Biologics
- Innogene Kalbiotech
- Bifarma Adiluhung
- Kalbe International
- Innolab Sains Internasional
- Pharma Metric Labs
- Saka Farma Laboratories
- Dankos Farma
- Hexpharm Jaya Laboratories
- Hale International
- Finusolprima Farma Internasional
- Kalbe Milko Indonesia
- Enseval Putera
- Indogravure
- Kalbe Morinaga
- Kalbe Vision
- Kalventis
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen.
History
Kalbe Farma was founded on September 10, 1966, by 6 siblings, K.L. Tjoen, Theresia H. Setiady, Khouw Lip Swan, Khouw Lip Boen (Also Known As: Dr. Boenyamin Setiawan), Maria Karmila, and F. Bing Aryanto. Kalbe Farma first began operations in a house garage that was owned by the founders.
In May 2020, Kalbe Farma signed a Memorandum of Understanding with South Korean pharmaceuticals company Genexine Inc. to develop a vaccine for the new corona virus or COVID-19.
References
References
- (2023-01-13). "Our Story".
- (1 October 2017). "Anti-abortion MP Jacob Rees-Mogg admits profits from abortion pills". Evening Standard.
- "Kalbe Farma and South Korea's Genexine to Start Human Trial for Covid-19 Vaccine".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Kalbe Farma — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report